Procurement Summary
Country : USA
Summary : Non-Standard Laboratory Tests for Antibody Screen Testing
Deadline : 12 Apr 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 81336745
Document Ref. No. : NOI-NIAID-2168188
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Mayo Clinical Laboratories, Rochester, MN 55901
Complete Blood Count (CBC) with differential CAT# CBC QTY: 40Serum immunoglobulin CAT # IMMG QTY: 40Serum immunoglobulin subclasses CAT # IGGS QTY: 40 Serum Diphteria Tetanus vaccine titer CAT # DTABS QTY: 40 Serum varicella titer CAT # VZPG QTY: 40Serum rubella titer CAT # RBPG QTY: 40Screening for antibodies in serum of individuals with SMAD4 variants is needed. Results will be returned directly to us and used for research purposes only.
Sole Source Justification: The quantification of immunoglobulin subclasses assay (cat IGGS) is exclusively performed by Mayo Labs, and is not available from another vendor. This testing is a continuation of a project to be compared to data collected from our previous cohort of patients at NIH.
Due to limitations on blood draw volumes, multiple tests will be performed on a single sample. Thus all of the tests requested must be performed by single vendor.
In order for the data collected from this new cohort of patients to be compared to data collected from our previous cohort of patients, the exact same test must be performed by the same vendor. The previous data was generated by Mayo Labs. Based on this vendor having performed the previous tests, for the continuity of the research and to ensure data research is not flawed, altered or compromised from using another source during a continued project or protocol, it is critical to have the same testing performed by the same source, in this case, Mayo Clinical Laboratories.
The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency req...
Active Contract Opportunity
Notice ID : NOI-NIAID-2168188
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 05, 2023 01:19 pm EDT
Original Response Date: Apr 12, 2023 04:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date:
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - MEDICAL- LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services
Place of Performance: Bethesda, MD 20814 USA
Documents
Tender Notice